Theophylline 60219-2045-03
- Manufacturer
- Amneal Pharmaceuticals Ny Llc
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- March 27, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA216276
Need to source Theophylline? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Theophylline Anhydrous | 300 mg/1 |
Drug Class
Methylxanthine [EPC]Methylxanthine [EPC]Xanthines [CS]
Selected Package
60219-2045-03Selected30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (60219-2045-3)
Other packages for this product(3)
100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (60219-2045-1)
500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (60219-2045-5)
1000 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (60219-2045-7)